- DermTech reported Q2 2021 earning recently, on August 4, 2021.
- In the quarter, Dermtech beat both internal and analyst revenue estimates, but they missed analyst earnings by $0.06.
- The major metrics that impressed from the quarter was the strong revenue growth, along with their increased customer count, mitigating one of the biggest risks I have with Dermtech.
- Because of their strong quarter, DermTech moved higher on my watchlist, but due to the extremely high valuation, It will stay on the watchlist temporarily.
For further details see:
DermTech: Becoming More Appealing, Despite Nosebleed Valuation